Michael O. Fleming Net Worth

The estimated Net Worth of Michael O. Fleming is at least $1.72 Million dollars as of 3 May 2013. Michael Fleming owns over 959 units of Amedisys stock worth over $1,714,652 and over the last 15 years Michael sold AMED stock worth over $9,686.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michael Fleming AMED stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Amedisys stock since 2013, according to the Form 4 filled with the SEC. Most recently Michael sold 959 units of AMED stock worth $9,686 on 3 May 2013.

The largest trade Michael's ever made was selling 959 units of Amedisys stock on 3 May 2013 worth over $9,686. On average, Michael trades about 120 units every 0 days since 2010. As of 3 May 2013 Michael still owns at least 17,728 units of Amedisys stock.

You can see the complete history of Michael Fleming stock trades at the bottom of the page.

What's Michael Fleming's mailing address?

Michael's mailing address filed with the SEC is 5959 S. SHERWOOD FOREST BLVD., , BATON ROUGE, LA, 70816.

Insiders trading at Amedisys

Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... und David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.

What does Amedisys do?

amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i

Complete history of Michael Fleming stock trades at Amedisys

Amedisys executives and stock owners

Amedisys executives and other stock owners filed with the SEC include:

• Paul Kusserow,
  Chairman of the Board, President, Chief Executive Officer
• Christopher Gerard,
  Chief Operating Officer
• Scott Ginn,
  Chief Financial Officer
• Sharon Brunecz,
  Chief Human Resource Officer
• David Kemmerly,
  Chief Legal and Government Affairs Officer
• Paul Berthold Kusserow,
  Chairman & CEO
• Michael North,
  Chief Information Officer
• Christopher T. Gerard,
  Pres, COO & Director
• Scott G. Ginn,
  Exec. VP & CFO
• David L. Kemmerly,
  Chief Legal & Gov. Affairs Officer
• Sharon Brunecz,
  Chief HR Officer
• Julie Klapstein,
  Independent Director
• Richard Lechleiter,
  Lead Independent Director
• Bruce Perkins,
  Independent Director
• Jeffrey Rideout,
  Independent Director
• Teresa Kline,
  Independent Director
• Molly Coye,
  Independent Director
• Vickie Capps,
  Independent Director
• Nick Muscato,
  Vice President of Strategic Finance
• Denise Bohnert,
  Chief Compliance Officer
• Janet Britt,
  Sr. VP of Billing & Collections
• Adam Holton,
  Chief People Officer
• Jennifer Guckert Griffin,
  Sr. VP, Deputy Gen. Counsel, Corp. Sec. & Interim Chief Legal Officer
• John Nugent,
  Chief Acquisitions Officer
• Kendra Kimmons,
  VP of Marketing & Communications
• Denise Bohnert,
  Chief Compliance Officer
• Michael P. North,
  Chief Information Officer
• Pete Hartley,
  CTO & Sr. VP of Bus. Operations Systems
• Jake L Netterville,
  Director
• Jeffrey D Jeter,
  Chief Compliance Officer
• Donald A Washburn,
  Director
• Nathaniel M Zilkha,
  Director
• David B. Pearce,
  Chief Compliance Officer
• Lawrence R Pernosky,
  Chief Human Resources Officer
• Martin B Howard,
  Chief Information Officer
• Ronald A Laborde,
  Director
• Stephen Seim,
  Chief Strategy Officer
• Gary D Willis,
  Chief Financial Officer
• Linda J. Hall,
  Director
• Jane Carmody,
  See Remarks
• Daniel P Mc Coy,
  Chief Operating Officer
• Alice A Schwartz,
  CIO
• Susan Sender,
  See Remarks
• Asset Management Llc Kohlbe...,
  
• Allyson Guidroz,
  Chief Accounting Officer
• Richard M Ashworth,
  President and CEO
• Larry R Graham,
  COO
• Donald Jr Loverich,
  Principal Accounting Officer
• John F Giblin,
  Chief Financial Officer
• Gregory H Browne,
  Chief Financial Officer
• David Nierenberg,
  10% owner
• John Hank Linden,
  Chief Information Officer
• Listed Ltd Terra,
  10% owner
• Tide Capital, Llc North Tid...,
  
• Peter Ricchiuti,
  Director
• Michael O. Fleming,
  Chief Medical Officer
• David R Bucey,
  General Counsel and Secretary
• David R Pitts,
  Director
• William F Borne,
  CEO
• T A Jr Barfield,
  Chief Development Officer
• Dale E Redman,
  Chief Financial Officer
• Michael D Snow,
  Chief Operating Officer
• Ivanetta Davis Samuels,
  Director
• Adam Y Holton,
  Chief People Officer